Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
In the article “Reduction of Alcohol Drinking in Young Adults by Naltrexone: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Efficacy and Safety” by Stephanie S. O’ Malley, PhD, and colleagues published in the February 2015 issue (J Clin Psychiatry 2015;76[2]:e207-e213), in Figure 1, the numbers of participants who discontinued intervention have been corrected as follows. In the naltrexone condition, the total n = 9 (not interested, n = 6; family emergency, n = 1; medical contraindication, n = 1; adverse event/not interested, n = 1). In the placebo condition, the total n = 7 (not interested, n = 6; medical contraindication, n = 1).
Correction:
In the article “Reduction of Alcohol Drinking in Young Adults by Naltrexone: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Efficacy and Safety” by Stephanie S. O’ Malley, PhD, and colleagues published in the February 2015 issue (J Clin Psychiatry 2015;76[2]:e207-e213), in Figure 1, the numbers of participants who discontinued intervention have been corrected as follows. In the naltrexone condition, the total n = 9 (not interested, n = 6; family emergency, n = 1; medical contraindication, n = 1; adverse event/not interested, n = 1). In the placebo condition, the total n = 7 (not interested, n = 6; medical contraindication, n = 1).
Author Affiliations
References (1)
Save
Share
Cite
